Motor and sensory neurons of the periphery are among the largest cells, with volumes up to 5,000 times that typical for animal cells. Most of this volume is acquired just after stable synapse formation and concomitant with myelination, during which time the axons grow in diameter by more than an order of magnitude. One basic cell biological question is how this volume expansion, a key component for conduction velocity, is mediated. An essential feature of this is an """"""""outside-in"""""""" signaling cascade from the myelinating cell that targets phosphorylation of the neurofilament subunit NF-M. Using gene replacement in mice to produce NFM that cannot be phosphorylated or that mimics phosphorylation, the effects of eliminating or chronically modifying this signaling target will be determined. This will include a focus on identification of putative interfilament crosslinkers that function to support survival and growth of motor neurons, including a search for components that may selectively bind to phosphorylated neurofilaments. In a second aim, a proportion of dominantly inherited ALS arises from mutation in superoxide dismutase (SOD1). Although we previously demonstrated that toxicity is non-cell autonomous, requiring damage generated in multiple cell types, we will now identify those cell types by selectively removing mutant SOD1 expression from individual cell types using Cre recombinase mediated gene deletion. As to the mechanism of intracellular damage, the role in toxicity from selective association of mutant SOD1 with spinal cord mitochondria will be determined. Mixed cultures of normal and mutant motor neurons and/or non-neuronal supporting cells will be used to identify how toxicity is developed non-cell autonomously. Laser capture microdissection and DMA arrays will be used to determine how motor neurons are damaged by mutant SOD1. Finally, following from our discovery of selective mutant association with spinal mitochondria, the mechanism for this and its role in toxicity will be determined with purified components. ? ?

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Method to Extend Research in Time (MERIT) Award (R37)
Project #
2R37NS027036-18
Application #
6927757
Study Section
Synapses, Cytoskeleton and Trafficking Study Section (SYN)
Program Officer
Refolo, Lorenzo
Project Start
1989-04-01
Project End
2009-04-30
Budget Start
2005-05-01
Budget End
2006-04-30
Support Year
18
Fiscal Year
2005
Total Cost
$572,780
Indirect Cost
Name
Ludwig Institute for Cancer Research
Department
Type
DUNS #
627922248
City
La Jolla
State
CA
Country
United States
Zip Code
92093
Gao, Fen-Biao; Richter, Joel D; Cleveland, Don W (2017) Rethinking Unconventional Translation in Neurodegeneration. Cell 171:994-1000
Winkler, Ethan A; Sengillo, Jesse D; Sagare, Abhay P et al. (2014) Blood-spinal cord barrier disruption contributes to early motor-neuron degeneration in ALS-model mice. Proc Natl Acad Sci U S A 111:E1035-42
Crotti, Andrea; Benner, Christopher; Kerman, Bilal E et al. (2014) Mutant Huntingtin promotes autonomous microglia activation via myeloid lineage-determining factors. Nat Neurosci 17:513-21
Kang, Shin H; Li, Ying; Fukaya, Masahiro et al. (2013) Degeneration and impaired regeneration of gray matter oligodendrocytes in amyotrophic lateral sclerosis. Nat Neurosci 16:571-9
Lobsiger, Christian S; Boillée, Severine; Pozniak, Christine et al. (2013) C1q induction and global complement pathway activation do not contribute to ALS toxicity in mutant SOD1 mice. Proc Natl Acad Sci U S A 110:E4385-92
Parone, Philippe A; Da Cruz, Sandrine; Han, Joo Seok et al. (2013) Enhancing mitochondrial calcium buffering capacity reduces aggregation of misfolded SOD1 and motor neuron cell death without extending survival in mouse models of inherited amyotrophic lateral sclerosis. J Neurosci 33:4657-71
Foust, Kevin D; Salazar, Desirée L; Likhite, Shibi et al. (2013) Therapeutic AAV9-mediated suppression of mutant SOD1 slows disease progression and extends survival in models of inherited ALS. Mol Ther 21:2148-59
Kordasiewicz, Holly B; Stanek, Lisa M; Wancewicz, Edward V et al. (2012) Sustained therapeutic reversal of Huntington's disease by transient repression of huntingtin synthesis. Neuron 74:1031-44
Polymenidou, Magdalini; Cleveland, Don W (2012) Prion-like spread of protein aggregates in neurodegeneration. J Exp Med 209:889-93
Da Cruz, Sandrine; Parone, Philippe A; Lopes, Vanda S et al. (2012) Elevated PGC-1? activity sustains mitochondrial biogenesis and muscle function without extending survival in a mouse model of inherited ALS. Cell Metab 15:778-86

Showing the most recent 10 out of 71 publications